Literature DB >> 23669451

Differences in pain management between hematologists and hospitalists caring for patients with sickle cell disease hospitalized for vasoocclusive crisis.

Nirmish Shah1, Margo Rollins, Daniel Landi, Radhika Shah, Jonathan Bae, Laura M De Castro.   

Abstract

OBJECTIVES: Sickle cell disease (SCD) is a chronic disease characterized by multiple vaso-occlusive complications and is increasingly cared for by hospitalists. The purpose of this study is to examine differences in pain management between hematologists and hospitalists.
METHODS: We performed a single-institution, retrospective review of pain management patterns and outcomes in adult SCD patients hospitalized for vaso-occlusive crisis.
RESULTS: Over 26 months, we found a total of 298 patients (120 cared for by the hematologists and 178 by hospitalists), with a mean age of 32 (range 19-58). Patients cared for by hospitalists had a lower total number of hours on a patient controlled analgesia (PCA) device (171 vs. 212 hours, P=0.11). Hospitalists also were significantly more likely to utilize demand only PCA (42% vs. 23%, P=0.002) and had a significantly lower rate of using both continuous and demand PCA (54% vs. 67%, P=0.04). In addition, patients cared for by hospitalists had a significantly shorter hospitalization (8.4 days) compared to hematologists (10 days, P=0.04) with a non-significant difference in 7 and 30 day readmission rates (7.2% vs. 6.7% and 40% vs. 35% respectively).
CONCLUSION: We found patients cared for by hospitalists more frequently utilized home oral pain medication during admission, had shorter lengths of hospitalization, and did not have a significant increase in readmission rates.

Entities:  

Mesh:

Year:  2014        PMID: 23669451      PMCID: PMC3779519          DOI: 10.1097/AJP.0b013e318295ec04

Source DB:  PubMed          Journal:  Clin J Pain        ISSN: 0749-8047            Impact factor:   3.442


  10 in total

1.  Executive summary: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Gordon H Guyatt; Elie A Akl; Mark Crowther; David D Gutterman; Holger J Schuünemann
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

2.  Opioid patient controlled analgesia use during the initial experience with the IMPROVE PCA trial: a phase III analgesic trial for hospitalized sickle cell patients with painful episodes.

Authors:  Carlton D Dampier; Wally R Smith; Hae-Young Kim; Carrie Greene Wager; Margaret C Bell; Caterina P Minniti; Jeffrey Keefer; Lewis Hsu; Lakshmanan Krishnamurti; A Kyle Mack; Donna McClish; Sonja M McKinlay; Scott T Miller; Ifeyinwa Osunkwo; Phillip Seaman; Marilyn J Telen; Debra L Weiner
Journal:  Am J Hematol       Date:  2011-09-22       Impact factor: 10.047

Review 3.  Frequently asked questions by hospitalists managing pain in adults with sickle cell disease.

Authors:  Wally R Smith; Lanetta B Jordan; Kathryn L Hassell
Journal:  J Hosp Med       Date:  2011-05       Impact factor: 2.960

4.  Acute care utilization and rehospitalizations for sickle cell disease.

Authors:  David C Brousseau; Pamela L Owens; Andrew L Mosso; Julie A Panepinto; Claudia A Steiner
Journal:  JAMA       Date:  2010-04-07       Impact factor: 56.272

5.  Hospital readmission for adult acute sickle cell painful episodes: frequency, etiology, and prognostic significance.

Authors:  Samir K Ballas; Margaret Lusardi
Journal:  Am J Hematol       Date:  2005-05       Impact factor: 10.047

6.  The DEDUCE Guided Query tool: providing simplified access to clinical data for research and quality improvement.

Authors:  Monica M Horvath; Stephanie Winfield; Steve Evans; Steve Slopek; Howard Shang; Jeffrey Ferranti
Journal:  J Biomed Inform       Date:  2010-12-02       Impact factor: 6.317

7.  Inpatient management of sickle cell pain: a 'snapshot' of current practice.

Authors:  Scott T Miller; Hae-Young Kim; Debra Weiner; Carrie G Wager; Dianne Gallagher; Lori Styles; Carlton D Dampier
Journal:  Am J Hematol       Date:  2012-01-09       Impact factor: 10.047

8.  A comparison of two regimens of patient-controlled analgesia for children with sickle cell disease.

Authors:  N O Trentadue; M K Kachoyeanos; G Lea
Journal:  J Pediatr Nurs       Date:  1998-02       Impact factor: 2.145

9.  Pain management in sickle cell disease: palliative care begins at birth?

Authors:  Lennette Benjamin
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2008

10.  Survival of children with sickle cell disease.

Authors:  Charles T Quinn; Zora R Rogers; George R Buchanan
Journal:  Blood       Date:  2004-02-05       Impact factor: 22.113

  10 in total
  2 in total

1.  Derivation and preliminary validation of a risk score to predict 30-day ED revisits for sickle cell pain.

Authors:  Jeffrey Glassberg; Jena Simon; Nilesh Patel; Jordan M Jeong; Justin J McNamee; Gary Yu
Journal:  Am J Emerg Med       Date:  2015-07-17       Impact factor: 2.469

2.  Management of Sickle Cell Disease Super Utilizers.

Authors:  Gary A Johnson
Journal:  West J Emerg Med       Date:  2017-01-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.